Dr. Martin Schloh
After completing his doctorate in chemistry at the Massachusetts Institute of Technology (MIT) in Cambridge, M.A., Dr. Martin Schloh worked at Bayer AG and then at Bayer Pharma
in research & development as well as marketing for eight years. Subsequently, he has been active as partner and consultant with focus on pharmaceuticals and healthcare for various consultancies, such as:
- Roland Berger Strategy Consultants,
- PricewaterhouseCoopers,
- A.T. Kearney und
- Oliver Wyman.
In this role Martin Schloh developed market entry strategies and business and cooperation models for many companies in various international markets. He was responsible for numerous commercial due diligence projects in pharmaceuticals, biotechnology, OTC, medical technology, clinics, nursing homes, and health IT.
Dr. Martin Schloh is vice president of the German-Chinese Society for Medicine.
Contact and network with Dr. Martin Schloh:
Project track record
Consulting & Strategy
Turnaround strategy, portfolio optimisation and support for finding partners
Pharmaceuticals China
Market entry strategy and business organisation after integration in Eastern Europe and Russia
Pharmaceutical companies (Top 5) CEE / Russia
Sales force organisation, targeting and support of sales-up programmes
Pharmaceuticals EU Top 5
Commercial due diligence and market assessment for a dialysis provider
Medical technology (service) Europe
Best-practice market access study in selected oblasts and regions of Russia
Pharmaceuticals Russia
Turnaround strategy and portfolio optimisation
Pharmaceuticals production (CMO) Spain
Launch preparedness assessment and launch plan for a monoclonal antibody in mCRC
Pharmaceuticals EU Top 5
EUCOMED sector study for the reimbursement of telemedical functions of CIEDs
Medical technology EU Top 5
Market entry study and search for cooperation partners for an OTC wound care product portfolio.
Pharmaceuticals China
Benchmarking best practice in regulatory affairs
Pharmaceuticals Germany, Sweden, France, UK, Taiwan, Turkey, Australia
Market entry strategy in Russia and Eastern Europe
Biotech RUS & CIS, Eastern Europe
Market potential analysis of a selected orphan-drug portfolio
Pharmaceuticals EU Top 5
Audit and program management for the market entry strategy of a MAB in oncology
Pharmaceuticals Japan
Market entry study for a CNS portfolio
Biotech Germany, Austria and Switzerland
Strategy development and definition of marketing measures for an allergy test
Pharmaceuticals Germany, France, the Netherlands
Market entry strategy oncology and CNS
Pharmaceuticals South Korea
Market potential of a new POCT test in cardiology
Medical technology Germany
Market entry strategy in Russia and Eastern Europe
Pharmaceuticals HQ Europe
Operations & Management
Interim management and turnaround of the company
Pharmaceuticals Germany
Market entry
Biotechnology Germany, Austria, Switzerland, and Scandinavia
Turnaround management and portfolio optimisation
Pharmaceuticals production (CMO) Spain
Organisation of the function international export, development of international marketing concepts
Biotechnology globally, internationally
Turnaround management, portfolio optimisation and support for finding partners
Pharmaceuticals China
Reorganisation of the company and interim management of a pharmaceutical sales company in Germany for the owner in India
Pharmaceuticals Germany
Structuring of global export activities, interim management of the export manager function
Pharmaceuticals Germany, globally
Turnaround of a company, extension of product portfolio, search for national cooperation partners
Pharmaceuticals Russia & CIS, Eastern Europe
Partnering & Licensing
Search for cooperation partners
Pharmaceutical Contract Manufacturing Organisation (CMO) Turkey
Support for business development and extension of product portfolio available only on prescription in Germany for a pharmaceutical manufacturer from India
Pharmaceuticals Germany
Market entry strategy and search for cooperation partners for an OTC wound care product portfolio.
Pharmaceuticals China
Development of a partner-based market launch strategy in medicinal pain therapy
Pharmaceuticals Spain, Portugal
Product search for the pharmaceuticals market in Russia
Pharmaceuticals Germany, Russia
Turnaround management, portfolio optimisation, and support for finding partners
Pharmaceuticals China
Mergers & Acquisitions
Commercial due diligence of a leading generics company
Private equity Germany
Sale of the company
Pharmaceuticals production (CMO) Switzerland
Commercial due diligence
Private equity (CMO) France
Sale of the company
Pharmaceuticals Germany, USA
Commercial due diligence of a leading private hospital chain
Private equity Germany
Preparation of the sale of the company and the vendor commercial due diligence
Pharmaceutical company (Riemser) Germany
Development of the information memo, search for a buyer and first contact, support for the owners during the sale of the company
Mid-sized pharmaceutical company Germany
Commercial due diligence of a nursing home chain
Private equity Germany
Commercial due diligence of a detoxification and burn-out clinic
Private equity Germany
Due diligence and market assessment for a dialysis provider
Medical technology (service) Europe
Commercial due diligence of several leading private nursing home providers (both buy-side and sell-side)
Private equity Germany
